Increased ADAM9 expression has been reported in various cancers, such as hepatocellular carcinoma [21], prostate cancer [22], breast cancer [23, 24], non‐small cell lung cancer [25], skin melanoma [26] and glioma [27]. This evidence concerns the gene ADAM9 and prostate carcinoma.